TABLE 9.

Level of expression (a.u.) of the receptor CCR5 in monocyte subtypes, according to the treatment arms.

Monocytes	RT	RC	SET	SEC	p between groups*	p between groups #
						RT	RC	SET	SEC
Classical	5.29 (.24)	6.30 (1.35)	4.96 (.38)	5.18 (.22)	.263
Intermediate	5.10 (.59)	9.21 (3.27)	4.69 (.71)	4.54 (.87)	.424	.002	.019	.012	.030
Non-classical	3.63 (.23)	5.71 (1.79)	3.53 (.36)	3.47 (.34)	.302

Data represent means (standard errors of means–SEM). Kruskal-Wallis test, *comparisons between treatment arms and # comparisons between groups of monocytes (classical × intermediate × non-classical). RT: Rosuvastatin + Ticagrelor; RC: Rosuvastatin + Clopidogrel; SET: Simvastatin + Ezetimibe + Ticagrelor; SEC: Simvastatin + Ezetimibe + Clopidogrel;.au, fluorescence arbitrary units.